Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Compounds Essential to Human Function01:25

Compounds Essential to Human Function

10.2K
The human body is composed of cells that are fundamentally made up of several different molecules. These molecules are essential to carry out all physiological processes in the body and are broadly classified into organic and inorganic based on their chemical structures.
Inorganic Compounds Essential to Human Functioning
Inorganic compounds essential to human functioning include water, salts, acids, and bases. These compounds are inorganic, i.e., they do not have a carbon-hydrogen bond. Water...
10.2K
Essential Minerals for Bone Health01:31

Essential Minerals for Bone Health

6.4K
The minerals contained in all of the food we consume are essential for our organ systems. However, certain essential minerals, such as calcium, phosphorus, magnesium, manganese, and fluoride, largely affect bone health.
Calcium and Phosphorus
Calcium is a critical component of bones, especially in the form of calcium phosphate and calcium carbonate. Since the body cannot make calcium, it must be obtained from the diet. However, calcium cannot be absorbed from the small intestine without...
6.4K
Inhaled Medications01:23

Inhaled Medications

803
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
803
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

258
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
258
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

216
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
216
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

360
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
360

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The US Public Health Service Commissioned Corps at the American Medical Association: A Model Cross-Sector Collaboration to Promote Better Health for All.

Public health reports (Washington, D.C. : 1974)·2026
Same author

A Conceptual Model to Achieve Health Equity in APOL-1 Clinical Studies.

Health equity·2025
Same author

Demographic disparities in access to COVID-19 clinical trial sites across the United States: a geospatial analysis.

International journal for equity in health·2025
Same author

Developing a Charlson Comorbidity Index for the American Indian Population Using the Epidemiologic Data from the Strong Heart Study.

Journal of racial and ethnic health disparities·2024
Same author

Advancing Health Equity: Efforts to Expand Education on Skin Lightening Products.

Public health reports (Washington, D.C. : 1974)·2024
Same author

Bridging the Health Equity Gap: An Update from the U.S. Food and Drug Administration Office of Minority Health and Health Equity.

Health equity·2024
Same journal

Implementing Project Optimus in Oncology Dosage Optimization: Where are We Now?

Therapeutic innovation & regulatory science·2026
Same journal

Validation of the Ontario Protocol Assessment Level (OPAL) Tool for Assessing Clinical Trial Complexity and Supporting Workforce Planning in the Italian Clinical Research Context.

Therapeutic innovation & regulatory science·2026
Same journal

The Effect of Covariate Adjustment for Cox Regression in Cardiovascular Outcome Trials.

Therapeutic innovation & regulatory science·2026
Same journal

Current Status and Construction Requirements of Drug Clinical Trial Institutions in Sichuan Province in China.

Therapeutic innovation & regulatory science·2026
Same journal

The CARE Program: An Initiative of Patient-Focused Drug Development for Rare Diseases by NMPA.

Therapeutic innovation & regulatory science·2026
Same journal

Utilization of Clinical Evaluation Reports in Japan's Medical Device Approvals: Insights from Review Data on Approved Devices.

Therapeutic innovation & regulatory science·2026
See all related articles

Related Experiment Video

Updated: Feb 5, 2026

MRI-guided Focused Ultrasound Thalamotomy for Patients with Medically-refractory Essential Tremor
05:54

MRI-guided Focused Ultrasound Thalamotomy for Patients with Medically-refractory Essential Tremor

Published on: December 13, 2017

14.9K

Essential Medication Information for Patients: Ensuring Access.

Bryon M Pearsall1, Richardae Araojo1, Denise Hinton1

  • 11 Office of Medical Policy Initiatives, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA.

Therapeutic Innovation & Regulatory Science
|September 20, 2018
PubMed
Summary
This summary is machine-generated.

The US Food and Drug Administration (FDA) is creating new patient medication information to ensure safe and effective use of prescriptions. This initiative aims to provide clear, up-to-date details for every prescribed medication.

Keywords:
consumer informationconsumer information handoutdrug information servicesdrug labelingpatient education handoutpharmaceutical preparations

More Related Videos

Transradial Access Chemoembolization for Hepatocellular Carcinoma Patients
05:31

Transradial Access Chemoembolization for Hepatocellular Carcinoma Patients

Published on: September 20, 2020

6.2K
Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement
08:50

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement

Published on: March 26, 2018

12.3K

Related Experiment Videos

Last Updated: Feb 5, 2026

MRI-guided Focused Ultrasound Thalamotomy for Patients with Medically-refractory Essential Tremor
05:54

MRI-guided Focused Ultrasound Thalamotomy for Patients with Medically-refractory Essential Tremor

Published on: December 13, 2017

14.9K
Transradial Access Chemoembolization for Hepatocellular Carcinoma Patients
05:31

Transradial Access Chemoembolization for Hepatocellular Carcinoma Patients

Published on: September 20, 2020

6.2K
Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement
08:50

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement

Published on: March 26, 2018

12.3K

Area of Science:

  • Regulatory Science
  • Pharmaceutical Sciences
  • Public Health

Background:

  • Current prescription product information may not be consistently patient-oriented.
  • Ensuring patients receive essential medication details is crucial for safe usage.
  • The US Food and Drug Administration (FDA) recognizes the need for improved patient communication.

Purpose of the Study:

  • To outline the FDA's development of a new framework for Patient Medication Information (PMI).
  • To enhance the quality and timeliness of prescription product information for patients.
  • To promote the safe and effective use of prescribed medications through better patient understanding.

Main Methods:

  • The article describes the FDA's ongoing efforts and strategic approach.
  • Focus on developing a standardized, patient-centered information framework.
  • Collaboration and review processes to ensure information accuracy and accessibility.

Main Results:

  • Development of a new framework for Patient Medication Information.
  • Focus on providing patient-oriented details for each prescription.
  • Efforts to ensure essential prescription medication information reaches patients.

Conclusions:

  • The new FDA framework aims to improve patient comprehension of prescription medications.
  • Enhanced Patient Medication Information is expected to promote safer medication practices.
  • This initiative represents a significant step towards patient empowerment in healthcare decisions.